Nautilus Biotechnology Inc NAUT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/30/24 EDT
2.54quote price arrow down-0.03 (-1.17%)
Volume
183,809
52 week range
2.16 - 4.65
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.54
  • 52 Week High4.65
  • 52 Week High Date06/21/23
  • 52 Week Low2.16
  • 52 Week Low Date05/04/23

Key Stats

  • Market Cap317.749M
  • Shares Out125.10M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change-15.05

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.54
  • 52 Week High4.65
  • 52 Week High Date06/21/23
  • 52 Week Low2.16
  • 52 Week Low Date05/04/23
  • Market Cap317.749M
  • Shares Out125.10M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change-15.05

RATIOS/PROFITABILITY

  • EPS (TTM)-0.54
  • P/E (TTM)-4.70
  • Fwd P/E (NTM)-3.44
  • EBITDA (TTM)-74.256M
  • ROE (TTM)-21.95%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-642.20%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nautilus Biotechnology Inc

 

Profile

MORE
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform end-to-end solution comprised of the proteome analysis system, consumables, and...
Matthew Posard
Non-Executive Independent Chairman of the Board
Sujal Patel
President, Chief Executive Officer, Secretary, Director
Anna Mowry
Chief Financial Officer, Treasurer
Matthew Murphy J.D.
General Counsel
Address
2701 Eastlake Ave East
Seattle, WA
98102
United States

Top Peers

SYMBOLLASTCHG%CHG
AVIR
Atea Pharmaceuticals Inc
3.70-0.01-0.27%
BDTX
Black Diamond Therapeutics Inc
5.57-0.29-5.03%
TERN
Terns Pharmaceuticals Inc
5.05-0.05-0.98%
ATAI
ATAI Life Sciences NV
1.98+0.01+0.51%
ERAS
Erasca Inc
2.01-0.03-1.47%